Origin Materials (ORGN) Q3 2024 earnings summary

Executive summary

• Achieved successful Factory Acceptance Test for the first CapFormer PET cap system, demonstrating over 98% manufacturing efficiency and attended by customers representing over 100 billion annual cap consumption.

• Commercial production of PET caps is on track to begin in Q4 2024, with initial revenue expected in Q1 2025 and significant gross profit projected for 2025.

• Strong customer demand evidenced by a $100 million+ MOU for billions of caps over two years, positioning the company as a category leader in the $65 billion caps and closures market.

• The company shifted near-term focus to PET caps as the path to profitability, implementing a 28% workforce reduction in September 2024.

• Run-rate EBITDA positivity is targeted for the first half of 2026, with no additional equity capital required to achieve this milestone.

Financial highlights

• Q3 2024 revenue was $8.2 million, up from $7.1 million in Q3 2023, with nine-month revenue rising 40% year-over-year to $22.1 million.

• Net loss for Q3 2024 was $36.8 million, and for the nine months ended September 30, 2024, net loss widened to $70.2 million due to higher costs and impairment charges.

• Cash, cash equivalents, and marketable securities totaled $113.4 million as of September 30, 2024, with net cash used in operating activities of $45.1 million for the nine months.

• 2024 revenue guidance is $25–$35 million, with net cash burn expected between $55 million and $65 million.

• Gross margin for the nine months ended September 30, 2024 was approximately 2%, with cost of revenues at $21.7 million.

Outlook and guidance

• Commercial production of PET caps to begin in Q4 2024, with revenue ramping in Q1 2025 and significant increase expected in 2026.

• Run-rate EBITDA positivity is expected in the first half of 2026, with no need for additional equity capital before reaching this milestone.

• Demand for PET caps is expected to exceed supply for the foreseeable future, with plans to expand production capacity and enter new packaging markets.

• Minimum cash floor expected to be maintained on the path to EBITDA positivity.

• Substantial additional project financing and government incentives will be needed for further manufacturing expansion.